All data are based on the daily closing price as of May 12, 2026
s

ScinoPharm Taiwan

1789.TW
0.60 USD
-0.01
-1.64%

Overview

Last close
0.60 usd
Market cap
476.45M usd
52 week high
0.89 usd
52 week low
0.51 usd
Target price
0.57 usd

Valuation

P/E
113.5294
Forward P/E
40.3226
Price/Sales
4.8243
Price/Book Value
1.4876
Enterprise Value
422.11M usd
EV/Revenue
4.2072
EV/EBITDA
19.7474

Key financials

Revenue TTM
100.33M usd
Gross Profit TTM
34.77M usd
EBITDA TTM
19.19M usd
Earnings per Share
0.01 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd

About

ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
  • Symbol
    1789.TW
  • Exchange
    TW
  • Isin
    TW0001789006
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Chih-Hsien Lo
  • Headquarter
    Tainan City
  • Web site
    https://www.scinopharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top